| | JOURNAL OF EQUINE VETERINARY SCIENCE - GUIDE FOR AUTHORS
INTRODUCTION
Please consult this Guide for Authors for further
details on the requirements for submitting your paper to Journal of Equine Veterinary Science. The guidelines described in this
document should be adhered to carefully, to ensure high-quality and rapid publication of your manuscript.
Aims and Scope
The Journal of Equine Veterinary Science (JEVS) is an international publication designed for the practicing equine veterinarian,
equine researcher, and other equine health care specialist. Published monthly, each issue of JEVS includes original scientific
research, case reports, and review articles from leaders in the equine veterinary field. The journal also includes regular features such
as meeting and conference reports, news, and literature reviews to help equine practitioners stay current with the issues affecting their
practice. Breeders, trainers, and others involved in horse production and management will also find the Journal of Equine Veterinary
Science an invaluable resource.
Types of contribution
- Original Research Papers (Regular Papers)
-
Review Articles
- Case Reports
- Short Communications
- Clinical Techniques
Original
Research: Research or extensive clinical reports containing significant new findings. The material presented should be original
and not have been published elsewhere, except in a preliminary form. Papers will be reviewed by referees familiar with the subject matter
of the paper. Revisions are likely to be expected.
Review Articles should cover subjects falling within the scope of
the journal, which are of active current interest. Papers need not contain original work or ideas. They will be reviewed for completeness,
accuracy, style and suitability of content by referees familiar with the subject and the Editor-in-Chief. Revisions may be requested
Case Reports are practitioner-oriented reports meant to communicate the facts of an interesting case or series of cases.
Papers will be peer reviewed. Revisions are likely to be expected. The major concerns of the critique will be accuracy of diagnosis and
relevance to equine practice.
Short Communications are intended to provide quick publication of highly relevant and interesting
information. Manuscripts should contain original data and be limited to 2000 words. The number of tables and figures are limited to two
each. A limited number of references should be included. Manuscripts will be peer reviewed by two reviewers and the Editor.
Clinical
Techniques should describe a procedure or technique that must include 1) an overview and a description of the procedure; 2) a detailed
series of images and descriptive text describing each step of the procedure; 3) a detailed description of the instruments and other materials
needed to perform the procedure as well as trade name, manufacturer's name and address; 4) a summary or conclusion; and 5) references.
Additional information acceptable for this section would include topics of current interest to our colleagues whether it is a technique
or subject that can be used in the clinical situation. "New drug regimens for use in the horse" is one example of such a clinical topic
that has direct application to the equine.
Page Charges
This journal has no page charges.
BEFORE YOU BEGIN
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics
and http://www.elsevier.com/ethicalguidelines.
Policy and Ethics
The work described in your article
must have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments
involving humans http://www.wma.net/e/policy/b3.htm; EC Directive 86/609/EEC for animal experiments
http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated
at an appropriate point in the article.
Unnecessary cruelty in animal experimentation is not acceptable to the Editors of Journal
of Equine Veterinary Science.
Conflict of Interest
All authors must disclose any financial and personal relationships
with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest
include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or
other funding. See also
http://www.elsevier.com/conflictsofinterest.
Submission Declaration
Submission
of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published
lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors
and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Contributors
Each author is required to declare his or her individual contribution to the article: all authors must have
materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that
all authors have approved the final article should be true and included in the disclosure.
Authorship
All authors should
have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis
and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval
of the version to be submitted.
Disclosure
In line with the position of the International Committee of Medical Journal
Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be
prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However,
divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardize consideration of the manuscript.
Authors should fully disclose all posting in registries of results of the same or closely related work.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright
see
http://www.elsevier.com/copyright ). Acceptance of the agreement will ensure the widest possible dissemination
of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement. Subscribers may reproduce tables of contents or prepare lists of articles
including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions).
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained Author Rights
As an author you (or your employer or institution) retain certain rights; for details you are
referred to:
http://www.elsevier.com/authorsrights.
Role of the Funding Source
You are requested to
identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the
role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report;
and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated.
Please see http://www.elsevier.com/funding.
Funding Body Agreements and Policies
Elsevier has established
agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential
manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies
please visit http://www.elsevier.com/fundingbodies.
Sponsored Articles
This journal offers authors
the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please
view our Sponsored Articles page at http://www.elsevier.com/sponsoredarticles.
Language Services
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information
about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/languageediting
or our customer support site at http://epsupport.elsevier.com for more information.
Patent Details
Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included
in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
For further information see http://www.elsevier.com/patientphotographs.
Submission
Submission to this
journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically
converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript
source files are converted to PDF files at submission for the review process, these source files are needed for further processing after
acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing
the need for a paper trail.
Please submit your article via http://ees.elsevier.com/jevs.
Referees
Please submit, as part of the covering letter with the manuscript, the names, full affiliation (department, institution, city and country)
and email addresses of up to 5 potential Referees. Appropriate Referees should be knowledgeable about the subject but have no close connection
with any of the authors. In addition, Referees should be from institutions other than (and preferably countries other than) those of
any of the Authors. You may also suggest reviewers you do not want to review your manuscript, but please state your reasons for doing
so. The Editors retain the right to choose reviewers as deemed appropriate. All submissions will be reviewed by at least two anonymous
reviewers to evaluate them for originality, clear statement of a hypothesis, appropriate experimental design, completeness of methods,
a logical and comprehensive discussion, and conclusions that are supported by data.
PREPARATION
Use of Word-processing
Software
It is important that the file be saved in the native format of the word processor used. The text should be in single-column
format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article.
In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. Do not embed "graphically designed" equations or tables, but prepare these using the word processor's facility. When
preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid
is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional
manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Do not import the
figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript.
See also the section on Electronic illustrations. To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check"
functions of your word processor.
LaTeX
If the LaTeX file is suitable, proofs will be produced without rekeying the text.
The article should preferably be written using Elsevier's document class "elsarticle", or alternatively any of the other recognized classes
and formats supported in Elsevier's electronic submissions system, for further information see http://www.elsevier.com/wps/find/authorsview.authors/latex-ees-supported.
The Elsevier "elsarticle" LaTeX style file package (including detailed instructions for LaTeX preparation) can be obtained from the Quickguide:
http://www.elsevier.com/latex. It consists of the file: elsarticle.cls, complete user documentation for the class file,
bibliographic style files in various styles, and template files for a quick start.
Article Structure
Subdivision - Numbered
Sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1. (then 1.1.1., 1.1.2.,
...), 1.2., etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not
just refer to "the text". Any subsection may be given a brief heading. Each heading should appear on its own separate line, with one
blank line above and below each heading.
Introduction
State the objectives of the work and provide an adequate background, avoiding
a detailed literature survey or a summary of the results. In most cases, this section should not exceed approximately 2 double-spaced
pages.
Materials and Methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be
indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise, and should
correspond to data collection as described in Materials and Methods.
Discussion
This should explore the significance of the results
of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion
of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which
may stand alone or form a subsection of a Discussion or Results and Discussion section.
Essential Title Page Information
Title.
Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present
the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript
letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation,
including the country name, and, if available, the e-mail address of each author.
Corresponding author. Clearly indicate
who is willing to handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and
fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
Present/permanent
address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address"'
(or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work
must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise
and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions.
An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be
avoided, but if essential, they must be cited in full, without reference to the reference list. Also, non-standard or uncommon abbreviations
should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Keywords
Immediately after
the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid,
for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords
will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be
placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention
there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements
in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote
to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing
assistance or proof reading the article, etc.).
Nomenclature and Units
Follow internationally accepted rules and conventions:
use the international system of units (SI). If other quantities are mentioned, give their equivalent in SI. You are urged to consult
IUPAC: Nomenclature of Organic Chemistry: http://www.iupac.org/ for further information.
Accession Numbers
Accession numbers are unique identifiers in bioinformatics allocated to nucleotide and protein sequences to allow tracking of different
versions of that sequence record and the associated sequence in a data repository [e.g., databases at the National Center for Biotechnical
Information (NCBI) at the National Library of Medicine ('GenBank') and the Worldwide Protein Data Bank]. There are different types of
accession numbers in use based on the type of sequence cited, each of which uses a different coding. Authors should explicitly mention
the type of accession number together with the actual number, bearing in mind that an error in a letter or number can result
in a dead link in the online version of the article. Please use the following format: accession number type ID: xxxx (e.g., MMDB ID:
12345; PDB ID: 1TUP). Note that in the final version of the electronic copy, accession numbers will be linked to the appropriate
database, enabling readers to go directly to that source from the article.
Math Formulae
Present simple formulae in the
line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle,
variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations
that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes should
be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many word processors build footnotes
into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present
the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Image Manipulation
Whilst it is accepted that
authors sometimes need to manipulate images for clarity, manipulation for purposes of deception or fraud will be seen as scientific ethical
abuse and will be dealt with accordingly. For graphical images, this journal is applying the following policy: no specific feature within
an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable
if and as long as they do not obscure or eliminate any information present in the original. Nonlinear adjustments (e.g. changes to gamma
settings) must be disclosed in the figure legend.
Electronic Artwork
General Points
- Make sure you use uniform
lettering and sizing of your original artwork.
- Save text in illustrations as "graphics" or enclose the font.
- Only
use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol.
- Number the illustrations according
to their sequence in the text.
- Use a logical naming convention for your artwork files.
- Provide captions to illustrations
separately.
- Produce images near to the desired size of the printed version.
Submit each figure as a separate
file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless
of the application used, when your electronic artwork is finalized, please "save as" or convert the images to one of the following formats
(note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings.
Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a
minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications
please supply "as is".
Please do not:
- Supply embedded graphics in your word processor (spreadsheet, presentation)
document;
- Supply files that are optimized for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
-
Supply files that are too low in resolution;
- Submit graphics that are disproportionately large for the content.
Non-Electronic Artwork
Provide all illustrations as high-quality printouts, suitable for reproduction (which may include
reduction) without retouching. Number illustrations consecutively in the order in which they are referred to in the text. They should
accompany the manuscript, but should not be included within the text. Clearly mark all illustrations on the back (or - in case of line
drawings - on the lower front side) with the figure number and the author's name and, in cases of ambiguity, the correct orientation.
Mark the appropriate position of a figure in the article.
Color Artwork
Please make sure that artwork files are
in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you
submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g.,
ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color
reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please
indicate your preference for color in print or on the Web only. For further information on the preparation of electronic artwork, please
see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by
converting color figures to "gray scale" (for the printed version should you not opt for color in print) please submit in addition usable
black and white versions of all the color illustrations.
Figure Captions
Ensure that each illustration has a caption.
Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and
a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Text Graphics
Present incidental graphics not suitable for mention as figures, plates or schemes at the end of the article
and number them "Graphic 1", etc. Their precise position in the text can then be indicated. See further under Electronic artwork. If
you are working with LaTeX and have such features embedded in the text, these can be left, but such embedding should not be done specifically
for publishing purposes. Further, high-resolution graphics files must be provided separately.
Tables
Number tables consecutively
in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase
letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results
described elsewhere in the article.
References
Citation in Text
Please ensure that every reference cited in the
text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished
results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references
are included in the reference list they should follow the standard reference style of the journal and should include a substitution of
the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that
the item has been accepted for publication.
Web References
As a minimum, the full URL should be given and the date when the reference
was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also
be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included
in the reference list.
References in a Special Issue
Please ensure that the words 'this issue' are added to any references in
the list (and any citations in the text) to other articles in the same Special Issue.
Reference Style
Text: Indicate
references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s)
must always be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear
in the text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art
of writing a scientific article. J Sci Commun 2000;163:51-9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements of
style. 3rd ed. New York: Macmillan; 1979.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare
an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc;
1999, p. 281-304.
Note shortened form for last page number. e.g., 51-9, and that for more than 6 authors the first 6 should be listed
followed by "et al." For further details you are referred to "Uniform Requirements for Manuscripts submitted to Biomedical Journals"
(J Am Med Assoc 1997;277:927-934) (see also http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal Abbreviations
Source
Journal names should be abbreviated according to Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;
List of serial title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php; CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Supplementary Material
Elsevier accepts electronic supplementary material
to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting
applications, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online
alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com.
In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors
should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file.
For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Files can be stored on diskette, ZIP-disk or CD (either MS-DOS or Macintosh).
Submission Checklist
It is hoped that
this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult
this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated
as corresponding Author
- E-mail address
- Full postal address
- Telephone and fax numbers
All
necessary files have been uploaded
- Keywords
- All figure captions
- All tables (including title, description,
footnotes)
Further considerations
- Manuscript has been "spellchecked" and "grammar-checked"
References are
in the correct format for this journal
- All references mentioned in the Reference list are cited in the text, and vice versa
- Permission has been obtained for use of copyrighted material from other sources (including the Web)
- Color figures
are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on
the Web (free of charge) and in black-and-white in print
- If only color on the Web is required, black and white versions of
the figures are also supplied for printing purposes
For any further information please visit our customer support site
at http://epsupport.elsevier.com.
AFTER ACCEPTANCE
Use of the Digital Object Identifier
The Digital
Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string
which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore,
it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic
information.
The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters
B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed
never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if
we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can
download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download
Adobe Reader version 7 (or higher) available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions
on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function,
you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections
quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to
the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for
checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as
accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get
your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us
in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading
is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints
can be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF file is a watermarked
version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions
of use.
AUTHOR INQUIRIES
For inquiries relating to the submission of articles (including electronic submission where available)
please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set
up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently
asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs,
will be provided by the publisher.
Updated July 2010
|
| |
|